Dr. Sherif Michael
Gastroenterology (Gastroenterology Physician)
2403 Castillo St Ste 201
Santa Barbara, CA 93105
Who else practices at this address →
Santa Barbara County includes primary care (2% of residents) and mental health (21% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 227
Licensed in California since 2020, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
CA license A168839 (first issued 2020; delinquent) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Willis Knighton Medical Center Shreveport, LA
Medical groups
- Wk Pinnacle Gastroenterology (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 227
- Services billed
- 471
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 109 | 98 |
| Biopsy of large bowel using a flexible endoscope | 57 | 57 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 47 | 47 |
| New patient office or other outpatient visit, 30-44 minutes | 34 | 34 |
| Established patient office or other outpatient visit, 30-39 minutes | 32 | 32 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 31 | 31 |
| New patient office or other outpatient visit, 45-59 minutes | 26 | 26 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | 26 |
| Established patient office or other outpatient visit, 40-54 minutes | 18 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Santa Barbara, CA | 181 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Santa Barbara, CA | 48 |
| Famotidine Other prescribers in Santa Barbara, CA | 28 |
| Omeprazole Other prescribers in Santa Barbara, CA | 22 |
| Sucralfate Other prescribers in Santa Barbara, CA | 19 |
| Diphenoxylate-Atropine (diphenoxylate hcl/atropine) Other prescribers in Santa Barbara, CA | 18 |
| Creon (lipase/protease/amylase) Other prescribers in Santa Barbara, CA | 15 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Santa Barbara, CA | 15 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Santa Barbara, CA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 93 payments worth $1,815 in total to this clinician.
| Food and Beverage | $1,815 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $47,569 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
AbbVie Inc. · Active, not recruiting · NCT06880744 - A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP)
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.